Sun Pharma Management on Q4 Performance

Uday Baldota, CEO of Sun Pharma, said fourth quarter profit have been impacted by pricing pressure and supply constraints. The company was expecting approvals for some new products, which did not materialise leading to lower sales, Mr Baldota added.

Related Videos